Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97812964

Filing Date: 02/27/2023

To the Commissioner for Trademarks:

MARK: SEQUEL (Standard Characters, see mark)
The literal element of the mark consists of SEQUEL. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, DEKA Research & Development Corp., a corporation of New Hampshire, having an address of
      340 Commercial Street
      Manchester, New Hampshire 03101
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Infusion cartridges filled with medication; Adhesive overlays in the nature of adhesive medical tape, bandages, pouches and mounts for use with infusion pumps and associated devices.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 009:  Software as a Medical Device (SaMD), downloadable, for predicting analyte levels and adjusting infusion pump settings based on personalized data; Downloadable software in the nature of applications for mobile phone and smart phones providing information and education on managing, treating and living with chronic disease; batteries; battery chargers
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 010:  medical devices, namely, infusion and injection devices for administering drugs and measured amounts of solutions into the bloodstream over time; apparatus for monitoring blood analyte levels; wearable subcutaneous drug delivery devices, sold empty in the nature of injectors; on-body injectors; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of analytes in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 035:  Providing a trade-in and upgrade program for drug delivery and chronic disease management devices; Mail order, online and telephone pharmacy services featuring chronic disease management supplies medications, drugs and other prescriptions.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 041:  Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing chronic disease; Providing a website featuring general information related to chronic diseases, including advice on treatment options and chronic disease management; online medical reference databases for consumers and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Mark E. Tetreault. Mark E. Tetreault, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      340 Commercial Street
      Manchester, New Hampshire 03101
      United States
      mtetreault@dekaresearch.com
The docket/reference number is TM007.
Mark E. Tetreault submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Mark E. Tetreault

PRIMARY EMAIL FOR CORRESPONDENCE: mtetreault@dekaresearch.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): patents@dekaresearch.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $2450 has been submitted with the application, representing payment for 7 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /mark e. tetreault/   Date: 02/27/2023
Signatory's Name: Mark E. Tetreault
Signatory's Position: Senior IP Counsel
Signatory's Phone Number: Not Provided
Signature method: Signed directly within the form
Payment Sale Number: 97812964
Payment Accounting Date: 02/27/2023

Serial Number: 97812964
Internet Transmission Date: Mon Feb 27 11:20:28 ET 2023
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2023022711202936
8852-97812964-860832b72324e10bbb491288e1
77e999f16a34ab5fad632b8a5d9efff0dd182af0
-DA-20297413-20230227111736512776